Hermione Price

1.5k total citations · 1 hit paper
50 papers, 1.0k citations indexed

About

Hermione Price is a scholar working on Endocrinology, Diabetes and Metabolism, General Health Professions and Epidemiology. According to data from OpenAlex, Hermione Price has authored 50 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Endocrinology, Diabetes and Metabolism, 11 papers in General Health Professions and 11 papers in Epidemiology. Recurrent topics in Hermione Price's work include Diabetes Management and Research (16 papers), Diabetes Management and Education (15 papers) and Chronic Disease Management Strategies (11 papers). Hermione Price is often cited by papers focused on Diabetes Management and Research (16 papers), Diabetes Management and Education (15 papers) and Chronic Disease Management Strategies (11 papers). Hermione Price collaborates with scholars based in United Kingdom, Denmark and France. Hermione Price's co-authors include Richard I. G. Holt, Rury R. Holman, Andrej Janež, Michel Marre, Matthew Capehorn, Bruno Vergès, Andrei‐Mircea Catarig, Simon J. Griffin, Clare Whicher and Jazz Bartholomew and has published in prestigious journals such as Diabetes Care, Diabetologia and Nature Reviews Cardiology.

In The Last Decade

Hermione Price

45 papers receiving 981 citations

Hit Papers

Efficacy and safety of once-weekly semaglutide 1.0 mg vs ... 2019 2026 2021 2023 2019 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)
    2019 283 citations Matthew Capehorn, Andrei‐Mircea Catarig et al. Diabetes & Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hermione Price United Kingdom 15 719 241 144 138 132 50 1.0k
D. K. G. Andersson Sweden 14 395 0.5× 106 0.4× 68 0.5× 151 1.1× 130 1.0× 23 917
Priya M. John United States 14 831 1.2× 163 0.7× 244 1.7× 33 0.2× 211 1.6× 23 1.3k
Javier Cid‐Ruzafa United States 10 296 0.4× 166 0.7× 96 0.7× 42 0.3× 164 1.2× 20 1.1k
Donald O. Fedder United States 10 649 0.9× 116 0.5× 189 1.3× 64 0.5× 128 1.0× 26 1.2k
Karen Cheal United States 9 654 0.9× 138 0.6× 168 1.2× 57 0.4× 378 2.9× 10 1.3k
Julia Dixon United States 13 449 0.6× 122 0.5× 69 0.5× 176 1.3× 158 1.2× 51 1.2k
A. D. Morris United Kingdom 13 634 0.9× 123 0.5× 143 1.0× 40 0.3× 141 1.1× 19 990
Kubilay Karşıdağ Türkiye 14 703 1.0× 90 0.4× 134 0.9× 41 0.3× 332 2.5× 38 1.3k
Liisa Saarikoski Finland 14 323 0.4× 88 0.4× 71 0.5× 107 0.8× 289 2.2× 19 913
Marco Comaschi Italy 15 825 1.1× 102 0.4× 136 0.9× 43 0.3× 363 2.8× 34 1.2k

Countries citing papers authored by Hermione Price

Since Specialization
Citations

This map shows the geographic impact of Hermione Price's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hermione Price with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hermione Price more than expected).

Fields of papers citing papers by Hermione Price

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hermione Price. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hermione Price. The network helps show where Hermione Price may publish in the future.

Co-authorship network of co-authors of Hermione Price

This figure shows the co-authorship network connecting the top 25 collaborators of Hermione Price. A scholar is included among the top collaborators of Hermione Price based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hermione Price. Hermione Price is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Dambha‐Miller, Hajira, et al.. (2022). Home monitoring of haemoglobin A1c in diabetes: A systematic review and narrative synthesis on accuracy, reliability and patient acceptability. Diabetic Medicine. 40(4). e15033–e15033. 4 indexed citations
4.
Barnard‐Kelly, Katharine, Clare Whicher, Hermione Price, et al.. (2022). Liraglutide and the management of overweight and obesity in people with severe mental illness: qualitative sub-study. BMC Psychiatry. 22(1). 21–21. 11 indexed citations
5.
Cleal, Bryan, et al.. (2022). Prevalence of mental disorders in people living with type 1 diabetes: A systematic literature review and meta-analysis. General Hospital Psychiatry. 80. 1–16. 29 indexed citations
6.
Hodgson, Sam, et al.. (2021). Population stratification in type 2 diabetes mellitus: A systematic review. Diabetic Medicine. 39(1). e14688–e14688. 6 indexed citations
7.
Holman, Naomi, Peter Knighton, Sarah H. Wild, et al.. (2021). Completion of annual diabetes care processes and mortality: A cohort study using the National Diabetes Audit for England and Wales. Diabetes Obesity and Metabolism. 23(12). 2728–2740. 20 indexed citations
8.
Holt, Richard I. G., et al.. (2021). Introduction to the development of complex interventions. Postgraduate Medical Journal. 98(1166). 895–899. 2 indexed citations
9.
Raya, Pedro Mezquita, Francisco Javier Ampudia‐Blasco, Barnaby Hunt, et al.. (2019). Evaluating the long‐term cost‐effectiveness of fixed‐ratio combination insulin degludec/liraglutide (IDegLira) for type 2 diabetes in Spain based on real‐world clinical evidence. Diabetes Obesity and Metabolism. 21(6). 1349–1356. 14 indexed citations
10.
11.
Capehorn, Matthew, Andrei‐Mircea Catarig, Andrej Janež, et al.. (2019). Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10). Diabetes & Metabolism. 46(2). 100–109. 283 indexed citations breakdown →
12.
Whicher, Clare, Hermione Price, & Richard I. G. Holt. (2018). Mechanisms in endocrinology: Antipsychotic medication and type 2 diabetes and impaired glucose regulation. European Journal of Endocrinology. 178(6). R245–R258. 34 indexed citations
13.
Roberts, Emmert, Faith Matcham, Carol Kan, et al.. (2017). The prevalence of diabetes mellitus and abnormal glucose metabolism in the inpatient psychiatric setting: A systematic review and meta-analysis. General Hospital Psychiatry. 45. 76–84. 17 indexed citations
14.
George, Jyothis T., Paul Grant, Roselle Herring, et al.. (2012). One-third of doctors completing specialist training in diabetes fail to secure a substantive consultant post: Young Diabetologists’ Forum survey 2010. Clinical Medicine. 12(3). 244–247. 3 indexed citations
15.
George, Jyothis T., David Warriner, Hermione Price, et al.. (2011). Lack of confidence among trainee doctors in the management of diabetes: the Trainees Own Perception of Delivery of Care (TOPDOC) Diabetes Study. QJM. 104(9). 761–766. 57 indexed citations
16.
Price, Hermione, et al.. (2010). Taking training into your own hands. Clinical Medicine. 10(4). 349–351. 1 indexed citations
17.
Darbyshire, Julie, Rury R. Holman, & Hermione Price. (2009). Presenting the results of clinical trials to participants. Clinical Medicine. 9(5). 415–416. 4 indexed citations
18.
Price, Hermione & Rury R. Holman. (2009). Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?. Nature Reviews Cardiology. 6(3). 168–169. 7 indexed citations
19.
Price, Hermione, Ruth L. Coleman, Richard Stevens, & Rury R. Holman. (2008). Impact of using a non-diabetes-specific risk calculator on eligibility for statin therapy in type 2 diabetes. Diabetologia. 52(3). 394–397. 5 indexed citations
20.
Price, Hermione, et al.. (2002). Life is sweet in Fiji: the availability of diabetes healthcare and health education, and diabetes awareness amongst diabetic patients in Fiji. Practical Diabetes International. 19(6). 160–163. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. K. G. Andersson Breakdown of academic impact, for papers by Priya M. John Breakdown of academic impact, for papers by Javier Cid‐Ruzafa Breakdown of academic impact, for papers by Donald O. Fedder Breakdown of academic impact, for papers by Karen Cheal Breakdown of academic impact, for papers by Julia Dixon Breakdown of academic impact, for papers by A. D. Morris Breakdown of academic impact, for papers by Kubilay Karşıdağ Breakdown of academic impact, for papers by Liisa Saarikoski Breakdown of academic impact, for papers by Marco Comaschi
Rankless by CCL
2026